HIV drugs Stories

WHO approves injectable lenacapavir in major shift on HIV prevention
Charity Kilei  |  Jul 14, 2025

Lenacapavir is the first long-acting injectable HIV prevention drug that requires administration only twice a year. It offers a highly effective and c...

UNAIDS warns HIV crisis could claim 4 million lives by 2029 without urgent global funding
Bashir Mbuthia  |  Jul 10, 2025

Reported data for 2024 shows that 9.2 million people living with HIV were still not accessing life-saving treatment services last year.

FDA approves groundbreaking twice-yearly HIV prevention shot
Bashir Mbuthia  |  Jun 19, 2025

Unlike daily PrEP pills or injections given every two months, the shot could be more appealing to people who struggle with adherence or wish to avoid...

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case
Reuters  |  Mar 29, 2025

U.S. District Judge Zahid Quraishi in Trenton, New Jersey, ordered the drugmaker's Janssen unit to pay $360 million for violating the federal False Cl...

KEMSA releases ARVs targeting one million HIV patients after concerns over US aid cuts
Maureen Kinyanjui  |  Mar 15, 2025

The supplies will be distributed through a partnership with the Mission for Essential Drugs and Supplies, ensuring their efficient delivery to those i...

Mother-to-child HIV transmission rates in Kenya drop, but challenges remain
Maureen Kinyanjui  |  Nov 21, 2024

Despite this progress, experts warn that the current rates are still too high.

HIV prevention drug expected to be launched in Kenya next year
Maureen Kinyanjui  |  Oct 05, 2024

The drug, lenacapavir, is administered via an injection twice a year.

Stay ahead of the news! Click ‘Yes, Thanks’ to receive breaking stories and exclusive updates directly to your device. Be the first to know what’s happening.